Temporomandibular Disorders
Conditions
Brief summary
Background The purpose of the present controlled clinical trial was to assess the effect of a single 60 min application of transcutaneous electrical nervous stimulation (TENS) at sensory stimulation threshold (STS), compared to the application of motor stimulation threshold (MTS) as well as to untreatment, on the surface electromyographic (sEMG) and kinesiographic activity of patients with temporomandibular disorder (TMD). Methods Sixty female subjects, selected according to the inclusion/exclusion criteria, suffering from unilateral TMD in remission were assigned to MTS, STS or untreatment. Pre- and post-treatment differences in the sEMG activity of temporalis anterior (TA), masseter (MM), digastric (DA) and sternocleidomastoid muscles (SCM), as well in the interocclusal distance (ID), within group were tested using the Wilcoxon test, while differences among groups were assessed by Kruskal-Wallis test; the level of significance was set at p ≤ 0.01.
Interventions
DEVICETranscutaneous electrical nerve stimulation
Sponsors
University of L'Aquila
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes
Inclusion criteria
* age less than 30 years; * female gender * right-handed (7-10 points in Edinburgh inventory); * presence of complete permanent dentition, with the exception of the third molars; * normal occlusion; * diagnosis of unilateral arthrogenous TMD on the Research Diagnostic Criteria for TMD (RDC/TMD), Axis I, groups II and III
Exclusion criteria
* having pacemaker or other electrical devices * previous experience of TENS or biofeedback * systemic diseases * history of local or general trauma * neurological or psychiatric disorders * muscular diseases * cervical pain * bruxism diagnosed by the presence of parafunctional facets and/or anamnesis of parafunctional tooth clenching and/or grinding * pregnancy * assumption of anti-inflammatory, analgesic, antidepressant or myorelaxant drugs * fixed or removable prostheses * fixed restorations that affected the occlusal surfaces * previous or concurrent orthodontic or orthognathic treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sEMG values | 60 min |
Outcome results
None listed